In accordance with the treatment guidelines by Ogedegbe J et al. [2], the diagnosis of acromegaly is established by elevated age-specific IGF-1 levels and a failure to suppress GH production after an oral glucose tolerance test (OGTT). This evidence concerns the gene GH1 and acromegaly.